Table of Contents
Research & Development
Bristol Myers Squibb Signs Licensing Deal with Avidity Biosciences for Multiple Cardiovascular Targets | Abstract pdf html |
Shweta Gupta |
Licensing
Merck KGaA Signs Licensing Agreement with Abbisko for Pimicotinib | Abstract pdf html |
Lalit Mishra |
Mergers & Acquisitions
AbbVie to Acquire ImmunoGen for US$10.1 B | Abstract pdf html |
Lucy Haggerty |
AbbVie to Buy Cerevel Therapeutics for US$8.7 B to Bolster Neuroscience Portfolio | Abstract pdf html |
Lucy Haggerty |
Roche to Acquire Carmot Therapeutics for US$3.1 B | Abstract pdf html |
Ayush Saxena |

This work is licensed under a Creative Commons Attribution 3.0 License.